Genetron Holdings (Genetron Holdings) Additional Paid-In Capital : $1,003.31 Mil(As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Additional Paid-In Capital?

Genetron Holdings's quarterly additional paid-in capital increased from Dec. 2021 ($1,053.69 Mil) to Mar. 2022 ($1,057.82 Mil) but then stayed the same from Mar. 2022 ($1,057.82 Mil) to Jun. 2022 ($1,003.31 Mil).

Genetron Holdings's annual additional paid-in capital increased from Dec. 2020 ($1,018.09 Mil) to Dec. 2021 ($1,053.69 Mil) but then declined from Dec. 2021 ($1,053.69 Mil) to Dec. 2022 ($966.04 Mil).

Genetron Holdings Additional Paid-In Capital Historical Data

The historical data trend for Genetron Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Additional Paid-In Capital Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

1,018.09

1,053.69

966.04

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
Additional Paid-In Capital	Get a 7-Day Free Trial													1,038.11	1,053.69	1,057.82	1,003.31	966.04

Genetron Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Genetron Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.